The FGF9 gene helps guide growth before birth, especially in developing bones, joints, and a few other tissues. This gene plays an important role in the signals cells use to shape the skeleton. If the FGF9 gene does not work properly, some bones or joints may form differently, which can lead to fused joints in the fingers, hands, or elsewhere, and sometimes hearing changes. Changes in this gene are uncommon and are mostly discussed in medical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which are the working parts of cells. Others mainly help determine when certain processes happen, where they occur, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
FGF9Gene function
What if the gene works
Your cells use the FGF9 gene to send growth signals that help shape bones, joints, and some organs during development. It also helps guide normal growth in the lungs and nervous system.
Risk
What if the gene does not work
Variants in the FGF9 gene can cause abnormal bone and joint development, especially fusion in the elbows, knees, hands, or feet. Milder and more severe variants can affect when features appear and how extensive the fusion becomes.
Treatment
What does that mean for your treatment
No treatment or management approach tailored to pathogenic variants in the FGF9 gene is currently established. The FGF9 gene is being studied as a growth signal and possible biomarker or drug target in some cancers, but this has not changed routine care for inherited FGF9-related conditions.
Conditions associated with FGF9
Gene function
What if the gene works
The FGF9 gene helps cells send growth messages that shape developing tissues and support upkeep later in life. Its protein acts like a local messenger, telling nearby cells when to grow, specialize, or stay in balance. Understanding how the FGF9 gene works in the body helps explain normal bone, organ, and tissue development.
The FGF9 gene makes a messenger protein that nearby cells can receive and respond to. This helps coordinate when cells grow, divide, and take on the right job during normal development.
Its protein supports communication between cartilage cells and cells that build bone. This helps growing bones lengthen and mature in an organized way, especially before birth and during early growth.
During early development, this gene helps guide the forming of organs such as the lungs and parts of the brain. It gives nearby cells timing cues so tissues expand and arrange themselves in the right pattern.
In mature tissues, FGF9 continues to support steady cell communication and normal tissue maintenance. This can help the body replace worn cells and respond to everyday repair needs.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help make normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
FGF9 gene variants can change how the FGF9 protein folds, how much of it is released from the cell, and how strongly it binds to nearby targets. Some changes are mild and only partly alter signaling, while more disruptive variants can markedly affect stability, release, or binding. These FGF9 gene variant effects on protein signaling help explain why some variants are milder and others are linked to earlier or broader bone fusion in FGF9-associated skeletal conditions.
How variants are linked to conditions
Rare pathogenic variants in the FGF9 gene cause multiple synostoses syndrome type 3, a condition marked by unusual fusion of certain bones and joints, often affecting the fingers, elbows, knees, or feet. In families with this pattern, an FGF9 gene variant can confirm the diagnosis. This is a rare inherited condition, so these findings do not mean common FGF9 gene changes predict joint disease in the general population.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widely found in the general population. Most do not have a direct effect on health and simply represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the FGF9 gene. If you have a change in FGF9 or a family history linked to it, a doctor or genetic counselor can help explain what that may mean for your personal risk.
Inheritance of FGF9 variants
For families trying to understand how FGF9 gene variants are inherited, the well-established pattern is autosomal dominant. This means a person with a disease-causing variant in one copy of the FGF9 gene can pass it to a child, with a 1 in 2, or 50%, chance in each pregnancy. Sons and daughters can inherit it equally, and either parent can pass it on.
What does my FGF9 result mean for my family?
For the main recognized condition linked to the FGF9 gene, the family pattern is usually dominant, which means close relatives such as a parent, brother, sister, or child may also carry the same gene change and could have similar bone or joint findings. Each child of someone with a disease-causing FGF9 change has a 1 in 2, or 50%, chance of inheriting it. Some cases can start new in one person, so a parent does not always have the same change.
Genetic information
Genetic testing
How you find out about variants
FGF9 genetic testing usually uses a blood or saliva sample to look for variants in the FGF9 gene. A lab reads the gene’s DNA code, sometimes as part of a larger panel, and the result may show a disease linked variant, no relevant variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider testing for changes in the FGF9 gene if you or your child has unusual bone or joint fusion, especially in the fingers, elbows, or feet, or if these findings run in the family. Testing may also help clarify a diagnosis when doctors suspect a rare inherited bone growth condition.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies by the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts, so the same treatment may work better for one person and cause more side effects in another. This kind of variation is common and helps explain why medication response can differ from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. It studies relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. For a closer look at this subject, more information is available in the LearnHub.
Drugs influenced by the FGF9 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. Questions about side effects, trouble starting a new medicine, or changes in your health are best discussed with your doctor.
History
FGF9 was identified in the early 1990s during efforts to map and classify members of the fibroblast growth factor family. Initially understood only through visible traits, later recognized as tied to a specific gene, it was first described under a different name before being placed within the FGF group as evidence accumulated. From these first observations, research expanded steadily. Studies in animal models then linked the FGF9 gene to key steps in embryonic development, which helped establish it as an important signaling gene in developmental biology. Over time, scientists’ understanding of the FGF9 gene has changed as genetic studies connected rare variants to inherited conditions affecting bone growth and joint development.